SPM Active™ 30 capsules
SPM Active™ 30 capsules is a Practitioner-Grade product available for customers under the care of a practitioner.
Practitioner Products
To purchase any Practitioner Grade products you must have have a patient account with Health Freek.
Apply For An Account- SPM Active™ contains standardised and concentrated specialised proresolving mediators (SPMs) exclusive to Metagenics.
- SPM Active™ helps maintain general health, supports wellbeing.
- SPM Active™ is double strength for a convenient once daily dose.
SPM Active™ is a specific and targeted approach to facilitate theresolution phase in patients experiencing inflammation which may befailing to resolve in a timely manner. Unresolved inflammation can leadinto low-grade, chronic inflammation that may worsen existing disease states,impair recovery and negatively affect healthy ageing.3 Chronic disease is anincreasing health burden and it is now estimated that 1 in 3 Australians livewith at least one chronic inflammatory condition including arthritis and othermusculoskeletal disorders, cardiovascular disease and diabetes mellitus.4 Thesehealth issues are characterised by inflammatory processes disrupting healingand driving chronic states indicating the need for SPMs to help supporthealthy resolution outcomes.
SPMs found in SPM Active™ are lipid mediators that occur naturally inthe body and have been found in various human tissue (such as thebrain, lymph nodes and synovial fluid).5 SPMs orchestrate resolution at thesite of inflammation to assist tissue repair, healing, recovery and the return tohomeostasis.6 These mediators help to:
- Activate the resolution phase.
- Signal to, and recruit certain immune cells and inflammatory mediators.
- Repair damage and clearance of pathogens.
- Prevent further pathological inflammation without immunosuppression.7,8
Despite omega-3 EPA and DHA being precursors of SPMs, they do notpossess significant pro-resolving properties.9 Metagenics, in collaborationwith SPMs experts and world-renowned leaders in the field of resolutionphysiology, are the first to set the standard for defining SPMs within atherapeutic supplement. Using a refined, patent pending fractionation process,specific SPM fractions are standardised for consistent dosing and therapeuticpatient outcomes. The special fraction and ratio is isolated, concentrated andmeasured for bioactivity to verify the active SPMs 17-HDHA and 18-HEPE. Thisprocess is exclusive to Metagenics, providing an inflammation-specific solutionthat is truly Practitioner-only.
Lipinova™ SPM's is a trademark of SOLUTEX GC.
Patents:
Australia/AU 2013259503
New Zealand/NZ 702325